BLACK DIAMOND THERAPEU
3.2900
08-November-24 14:59:58
15 minutes delayed
Stocks
+0.1100
+3.46%
Today's range
3.1600 - 3.3800
ISIN
N/A
Source
NASDAQ
-
Black Diamond Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
05 Jan 2022 07:00:02 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Present at Upcoming Investor Conferences
08 Nov 2021 15:05:02 By Nasdaq GlobeNewswire
-
08 Nov 2021 06:45:00 By Nasdaq GlobeNewswire
-
21 Sep 2021 15:05:00 By Nasdaq GlobeNewswire
-
21 Sep 2021 06:45:00 By Nasdaq GlobeNewswire
-
12 Aug 2021 07:22:20 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics Announces Appointment of Mark Velleca, M.D., Ph.D. to Board of Directors
10 Aug 2021 06:45:00 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Present at Upcoming Investor Conferences
04 Aug 2021 06:45:00 By Nasdaq GlobeNewswire
-
19 May 2021 16:00:00 By Nasdaq GlobeNewswire
-
17 May 2021 06:45:00 By Nasdaq GlobeNewswire
-
07 May 2021 06:45:00 By Nasdaq GlobeNewswire
-
28 Apr 2021 09:38:27 By Nasdaq GlobeNewswire
-
10 Apr 2021 07:30:00 By Nasdaq GlobeNewswire
-
25 Mar 2021 06:45:00 By Nasdaq GlobeNewswire
-
10 Mar 2021 15:58:50 By Nasdaq GlobeNewswire
-
02 Mar 2021 15:05:00 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Present at Upcoming Investor Conferences
23 Feb 2021 06:45:00 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Present at the BMO Biopharma Spotlight Series
11 Feb 2021 15:15:00 By Nasdaq GlobeNewswire